Alopecia and its association with coronary heart disease and cardiovascular risk factors: a meta-analysis

Nelson Trieu1, Guy D Eslick1

  • 1The Whiteley-Martin Research Centre, Discipline of Surgery, The University of Sydney, Nepean Hospital, Penrith, New South Wales, Australia.

Insights

Alopecia increases the risk of coronary heart disease and related cardiovascular issues like hypertension and metabolic syndrome. Greater hair loss severity correlates with higher coronary heart disease risk.

Area of Science:

  • Dermatology
  • Cardiology
  • Endocrinology

Background:

  • Alopecia is linked to increased coronary heart disease (CHD) risk.
  • Associated cardiovascular disease (CVD) risk factors include hyperinsulinemia, insulin resistance, metabolic syndrome, dyslipidemia, and hypertension.

Purpose of the Study:

  • To quantitatively assess the risk of CHD and associated risk factors in individuals with alopecia.
  • To perform a meta-analysis to determine the pooled risk estimates.

Main Methods:

  • Systematic literature search across multiple databases.
  • Pooled odds ratios (OR) and 95% confidence intervals (CI) calculated using a random-effects model.

Main Results:

  • 31 studies with 29,254 participants showed alopecia is associated with increased CHD risk (OR 1.22, 95% CI: 1.07-1.39).
  • Significant associations found for hyperinsulinemia (OR 1.97), insulin resistance (OR 4.88), metabolic syndrome (OR 4.49), and elevated cholesterol and triglyceride levels.
  • Increased risk observed for hypertension, including higher systolic (OR 1.73) and diastolic blood pressures (OR 1.59).

Conclusions:

  • Alopecia is associated with a higher risk of coronary heart disease.
  • A dose-response relationship exists: greater alopecia severity correlates with increased CHD risk.
  • Alopecia is linked to increased risks of hypertension, hyperinsulinemia, insulin resistance, metabolic syndrome, and dyslipidemia.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...